Cell Culture Market Instruments And Consumables–Cell based diagnosis
According to the latest publication by Meticulous Research, Cell Culture market is expected to reach USD 21,058 million by 2022, at a CAGR of 10.7% during the forecast period of 2017 to 2022.
Cell culture
is an important tool in life science research for finding the cause and therapies
for the various chronic diseases. According to the study done, it was found
that the most common cause of the disease was abnormal metabolic pathways and
signaling mechanisms which are very difficult to detect.
Cell based
diagnosis is primarily based on the principle that cells are grown in
artificial environmental conditions using cell culture products such as media,
sera, and reagents. This cell based diagnosis uses in vitro laboratory
conditions and hence reduces discomfort. In addition, there are no limitations
in using number of live cells as millions of cells can be isolated from less
amount of specimen. It also resembles in terms of pathophysiology and metabolic
pathways with in vivo conditions which reduces the experimental cost and time.
In addition, the
The major
companies providing cell based diagnostic products in the global market are
Irvine Scientific, HiMedia Laboratories, Cell Culture Company (CCC), LLC, Merck
& Co., Incorporation, General Electric Healthcare (GE Healthcare), Agilent
Technologies, Thermo Fisher Scientific, PromoCell GmbH, Lonza, Corning
Incorporation, Becton Dickinson (BD), CellGenix GmbH, InVivo Gen, Sera Care
Life Sciences, and American Type Culture Collection (ATCC).
Contact
Us:
Viren Shrivastava
AVP- Global
Sales and Marketing
Meticulous
Research®
Tel:
+1-646-781-8004
Comments
Post a Comment